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Abstract Knowledge-based models for protein folding
assume that the early-stage structural form of a polypeptide
is determined by the backbone conformation, followed by
hydrophobic collapse. Side chain–side chain interactions,
mostly of hydrophobic character, lead to the formation of
the hydrophobic core, which seems to stabilize the structure
of the protein in its natural environment. The fuzzy-oil-drop
model is employed to represent the idealized hydrophobic-
ity distribution in the protein molecule. Comparing it with
the one empirically observed in the protein molecule
reveals that they are not in agreement. It is shown in this
study that the irregularity of hydrophobic distributions is
aim-oriented. The character and strength of these irregular-
ities in the organization of the hydrophobic core point to the
specificity of a particular protein’s structure/function. When
the location of these irregularities is determined versus the
idealized fuzzy-oil-drop, function-related areas in the
protein molecule can be identified. The presented model
can also be used to identify ways in which protein–protein
complexes can possibly be created. Active sites can be
predicted for any protein structure according to the
presented model with the free prediction server at http://
www.bioinformatics.cm-uj.krakow.pl/activesite. The impli-
cation based on the model presented in this work suggests
the necessity of active presence of ligand during the protein
folding process simulation.
Keywords Hydrophobic collapse . Protein folding .
Active site . Ligand binding
Introduction
Since the classic work by Kauzmann [1], hydrophobic
interactions have been confirmed to play a crucial role in
forming and stabilizing the protein tertiary structure [2–5].
It is generally accepted that globular proteins consist of a
hydrophobic core and a hydrophilic surface [6, 7]. The way
in which the amino acid sequence partitions a protein into
its interior and exterior has been described [8]. The inside
regions are densely packed chain sites where hydrophobic-
ity is observed to be at a local maximum, whereas the
outside regions correspond to less densely packed sites
where hydrophobicity is at a local minimum. The spatial
distribution of amino acid hydrophobicity has been used to
differentiate native and non-native protein structures [9–
12]. Irbäck and co-workers brought forward a proof for
nonrandom hydrophobicity structures in protein chains
[13]. A second-order hydrophobic moment was discussed
for description of protein hydrophobicity [14]. Detailed
analyses of the spatial variation of hydrophobicity, focused
on the region of transition between the protein interior and
exterior, were carried out for 30 relatively diverse globular
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proteins as well as for 14 decoys [15]. Apart from soluble
proteins, the distribution of apolar and polar residues has
provided comprehensive information about transmembrane
protein architecture [16–19]. The hydrophobic effect has
been suggested to be the dominant driving force in protein
folding [20–22].
The model presented in this paper is oriented on
localization of the area responsible for ligand binding or
protein–protein complex creation, based on the character-
istics of the spatial distribution of hydrophobicity in a
protein molecule. It is assumed that hydrophobicity changes
from the protein interior (maximal hydrophobicity) to the
exterior (close to zero hydrophobicity) according to the
three-dimensional Gauss distribution. It is generally accept-
ed that the core region is not well described by a spheroid
of buried residues surrounded by surface residues due to
hydrophobic channels that permeate the molecule [23, 24].
This being so, we should be able to identify regions with
high deviation versus the ideal model by making a simple
comparison of the theoretical (idealized according to the
Gauss function) and empirical spatial distribution of
hydrophobicity in a protein. The regions recognized by
high hydrophobicity density differences seem to reveal
functionally important sites in proteins.
The model presented here can be used for structure-
based prediction of the localization of active sites in
proteins of unknown function. It can also be used for
qualitative and quantitative analysis of known protein–
protein or protein–ligand complexes. The statistical method
introduced for assignment of theoretical hydrophobicity to
small ligands, combined with searches for equivalent




The following structures were selected for analysis of
proteins complexed with small ligands: myoglobin (PDB
ID: 1A6M) [25], subtilisin DY (PDB ID: 1BH6) [26],
carboxypeptidase A2 (PDB ID: 1DTD) [27], chymotrypsin
(PDB ID: 1GG6) [28], c-type lysozyme (PDB ID:1LMQ)
[29] and ribonuclease (PDB ID: 1RGE) [30]. The following
CAPRI targets were selected for studying the structures of
protein–protein complexes: transcriptional antiterminator
protein LicT (target 09, homodimer, PDB ID: 1H99) [31],
cohesin-dockerin complex (targets 11 and 12, PDB ID:
1OHZ) [32] and the complex between protein serine/
threonine phosphatase-1 (delta) and N-terminal domain of
the myosin phosphatase targeting subunit MYPT1 (target
14, PDB ID: 1S70) [33].
Theoretical (expected) hydrophobic core
The fuzzy-oil-drop model, which was applied to simulate
so-called hydrophobic collapse in the protein folding
process, represents the theoretical, idealized hydrophobic
core of the protein molecule. Such a hydrophobic core
surrounded by the spheres of gradually decreased hydro-
phobicity is assumed to be represented by a three-
dimensional Gauss function:
Htj ¼ 1Htsum exp














The value of Htsum represents the sum of theoretical
hydrophobicity of all the grid points. The value of the
probability distribution (as the value of the Gauss function
is usually interpreted) Htj is assumed to represent the
hydrophobicity density for the j-th grid point in the fuzzy-
oil-drop. The hydrophobicity maximum is localized in the
center of the ellipsoid and decreases in a distance-
dependent manner according to the three-dimensional
Gauss function. The mean value at which the Gauss
function reaches its maximum is localized at the (0,0,0)
point in a coordinate system. The standard deviation
represents the size of the drop (according the three-sigma
rule) depending on the length of the polypeptide under
consideration.
The protein molecule is localized with its geometrical
center at the origin of the coordinate system. The longest
distance between effective atoms (side chains represented
by the geometrical centers of the atoms present there)
determines the Z-axis. The Y-axis is oriented according to
the longest distance between the projections of the effective
atoms on the XY plane. The longest distance between the
projections of the effective atoms along the X-axis
determines the size of the drop.
For the orientation described above, the σx,σy,σz values
can be calculated. The value of the longest distances versus
the (0,0,0) point along each axis increased by 9 Ǻ (cut off
distance for hydrophobic interaction) divided by 3 gives
value of appropriate σ.
A grid (its size depends on the molecule size) is created
in three-dimensional space. The values of the Gauss
function can be calculated for each grid point. The values
of the Gauss function (representing the hydrophobicity
distribution) are standardized to give a value of the sum of
all values over all grid points equal to 1.0. The system of
grid points calculated in this way is treated as the ideal
fuzzy-oil-drop with a hydrophobicity distribution according
to the Gauss function.
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The Gaussian function makes it possible to calculate
hydrophobicity in each point of space. The grid system can
be created in step-wise form. In particular, the positions of
effective atoms can also be treated as grid points, which
collect the hydrophobic interaction of particular residue
(j-th) with all others localized closer than the cutoff
distance, and can further be treated as parameters describ-
ing a particular amino acid (j-th). This is why the
distribution of hydrophobicity density can be presented in
the form of a profile along the polypeptide.
Empirical oil-drop observed in proteins
The same grid points as described above are used to
calculate the empirical hydrophobicity distribution repre-
senting the empirical oil drop. The empirical hydrophobic-
ity attributed to each grid point represents interaction with
all effective atoms (below the cutoff distance). Generally,
the grid point by itself represents zero hydrophobicity. If
the grid point is localized in the place of effective atom of
particular residue, its hydrophobicity is equal to the
hydrophobicity of this residue. The observed hydrophobic-
ity is calculated according to the simple sigmoid function
previously proposed to quantitatively describe hydrophobic
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where Hoj represents the empirical hydrophobicity value
characteristic for the j-th grid point, Hri represents the hydro-
phobicity characteristic of the i-th amino acid, rij is the distance
between the j-th effective atom (generally j-th grid point) and
i-th effective atom of the amino acid, and c expresses the
cutoff distance, which has a fixed value of 9.0 Å following the
original paper [34]. The value of Hosum represents the sum of
observed hydrophobicity of all the grid points.
Applying this function requires attribution of hydropho-
bicity parameters to each amino acid. Many scales for
residue hydrophobicity are available. Some of them are
based on analysis of known protein 3D structures [6, 14,
35–38], while others are derived from the physicochemical
properties of amino acid side chains [39, 40]. Selection of
an appropriate scale seems crucial, so a new statistics-based
hydrophobicity scale for amino acids has been created.
The differences between idealized and empirical
oil-drop
Since the theoretical Ht and observed Ho distributions of
hydrophobicity are both standardized to 1.0, these two
distributions can be compared. The differences between the
theoretical and empirical distributions ΔHi express the
irregularity of hydrophobic core construction. For the i-th
residue, ΔHi is calculated as follows:
ΔHi ¼ Hti  Hoi ð3Þ
where Hti and Hoi are the theoretical and observed values
of hydrophobicity for the geometric center of the i-th
residue, respectively. The theoretical fuzzy-oil-drop and
empirical oil drop were calculated for all proteins taken into
consideration. A color scale was introduced to express the
magnitude of the differenceΔHi in a particular protein area,
visualizing the localization of these discrepancies in the
protein molecule. The one-dimensional profiles of ΔHi
were smoothed by averaging of the raw data using a five-
residue running window frame. This simple method gives a
legible curve without affecting the positions of dominant
local extrema.
Comparative analysis
Method oriented on active site recognition SuMo [41]
(http://www.sumo-pbil.ibcp.fr/cgi-bin/sumo-welcome)
was applied for comparative analysis. This method is
based on the comparisons against binding sites from the
PDB as criterion for active site recognition. The SuMo
method is a two-step procedure. The representation of a
protein structure by a set of chemical groups (unbound hydrogen
bond donors or acceptors, accessible sides of aromatic rings and
carboxylate, primary amide, etc.) is performed as a first step.
The comparison of preformatted data is made in the second step.
As a result, the list of similar active sites ordered according to
decreasing score corresponding to the size of thematched sites is
formed.
The results of SuMo and fuzzy-oil-drop-based were
compared with the protein crystal structure. The distances
below 12 Ǻ between the ligand centre of gravity and Cα of
sequential residues were used to define the amino acids
responsible for ligand binding.
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Fig. 1 One-dimensional profiles of ΔH per amino acid (left column)
and three-dimensional distribution of ΔH on protein surface (right
column) for lysozyme complexed with N-acetylglucosamine (a),
chymotrypsin complexed with N-acetyl-L-phenylalanyl trifluoromethyl
ketone (b), carboxypeptidase A2 inhibited by leech carboxypeptidase
inhibitor (c), subtilisin DY inhibited by N-benzyloxycarbonyl-Ala-Pro-
Phe-chloromethyl ketone (d), myoglobin complexed with heme (e) and
ribonuclease complexed with guanosine-2′-monophosphate (f). The
color scale expresses the magnitude of difference in a particular protein
surface area. The dark blue (thick line) ligands are localized at their
binding sites according to crystal structure. The 3-D structures were
received using the VMD program with ΔHi values put into the β-factor
column and taken as criteria for the color scale
668 J Mol Model (2007) 13:665–675
Results
Comparing the expected and observed oil drops
The results of comparing the idealized and empirical hydro-
phobicity distributions are shown in two forms: a one-
dimensional profile of ΔHi (as dependent on the localization
of the amino acid in the polypeptide chain), expressing the
magnitude of differences between expected and observed
hydrophobicity; and the three-dimensional distribution of
ΔHi (as it appeared on a particular part of the protein
surface). Figure 1 shows the results describing six proteins
Fig. 1 (continued)
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selected for analysis of proteins complexed with small
ligands. The left column represents the one-dimensional pro-
files of ΔHi. The color scale also visualizes these profiles.
The same color scale adopted for the three-dimensional distri-
bution of ΔHi is shown in the right column. The dark blue
(thick line) ligands, localized at their binding sites according
to crystal structure, reveal very good agreement between the
observed and predicted areas for potential interaction sites.
Fig. 2 One-dimensional profiles of ΔH per amino acid (left column)
and three-dimensional distribution of ΔH on protein surface (right
column) for cohesin-dockerin complex: results for cohesin (a), results
for dockerin (b); complex between protein Ser/Thr phosphatase 1 and
MYPT1: results for Ser/Thr phosphatase (c), results for MYPT1 (d);
and LicT homodimer (e). The color scale expresses the magnitude of
difference in a particular protein surface area
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Localization of biological function
Figure 2 also shows the localization of the area critical for
the biological function of protein molecules. The proteins
represent the case which can be called protein–protein
complex construction. The profile of ΔHi and its three-
dimensional distribution as it appears in the protein
complex are shown. Both partners’ binding sites can be
easily recognized. The irregularity of the hydrophobicity
distribution for the surface (hydrophobicity higher than the
expected), and the cavity (hydrophobicity lower then
expected) disturbing the regularity of the hydrophobicity
distribution, seem to be good markers for mutual interaction.
Comparative analysis
The amino acids recognized as active site by SuMo and
fuzzy-oil-drop model are given in Table 1. The residues
identified on the basis of distance criterion are also given in
Table 1.
The protein–protein complexes shown in the Fig. 2
have not been taken for this analysis due to SuMo
limitation, which excludes the protein–protein complex
creation.
The residues distinguished by fuzzy-oil-drop criterion
are directly identified by maxima shown in Fig. 1. Two
options are possible for the SuMo model: with and without
ligand defined. To make the comparison complete, both
forms were applied in this analysis. The score values are
given in parenthesis. The residues identified on the basis
of the crystal structure with distance (between Cα position
and ligand center of gravity). Figure 3 illustrates the
comparison of the residues identified as belonging to
active site.
The results of comparative analysis seem to represent
rather high accordance particularly taking into account
the character of the criteria used in these two methods.
They seem to be quite differentiated: the protein
molecule-oriented in fuzzy-oil-drop and ligand-oriented
in SuMo.
Fig. 2 (continued)
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Discussion and conclusion
Many proteins of unknown biological function, identified
on the basis of genome analysis, await a unified automated
method for determining their biological activity [42]. The
next step is to develop methods able to predict a protein’s
function from an examination of its structure. Some of the
techniques used to identify functionally important residues
from the sequence or structure are based on searching for
homologues of proteins of known function [43–46].
However, homologues need not have related activity,
particularly when the sequence identity is below 25%
Fig. 3 Comparison of the resi-
dues recognized as active site by
(bottom to top): fuzzy-oil-drop
method, crystal structure for the
distance < 10 Å (smaller rect-
angles) and <15 Å (largest
rectangles) and for the SuMo
method: circles for the ligand
defined and crosses for ligand
undefined
Protein Crystal-based D<10 Å (D<15 Å) SuMo Fuzzy-oil-drop
Ligand defined Ligand undefined
1A6M 42, 43, 64–72, 89–93, 97–99, 103,
104, 107 (25, 28–33, 39–46, 61–72,
86–108, 139, 142)
HEM: 92, 93, 97 (3.050) HEM: 92, 93, 97 (3.050) 39–44, 68–71, 96–110,
134–141HEM: 92, 93, 97 (3.050) HEM: 92, 93, 97 (3.050)
HEM: 42, 43, 44, 45 (2.700) FMN: 39, 40, 41, 103 (2.727)
1RGE 35–41, 54, 85, 86 (31–44, 49–57,
60–72, 80–89)
2GP: 36–41, 54, 65, 69, 85,
86 (11.013)
2GP: 36–41, 54, 65, 69, 85,
86 (11.013)
54–57, 65–72, 79–87
2GP: 36–41, 54, 65, 69, 85,
86 (10.188)
2GP: 36–41, 54, 65, 69, 85,
86 (10.188)
2GP: 65, 69, 86 (3.250) SGP: 37–41, 65, 69, 86 (9.296)
1LMQ 35, 44–46, 50–52, 57–61, 107–110
(31–36, 42–64, 69, 72, 80, 95, 98,
99, 103–114)
NAG: 3, 85, 86 (2.450) SUC: 35, 52, 57, 59, 107–109,
112 (6.738)
26–37, 54–60, 105–111
NAG: 40, 83–85 (2.400) BUL: 35, 52, 57, 59, 107–109,
111 (6.738)
NAG: 40, 83, 85 (2.400) NAG-NAG: 35, 52, 57, 59,
107–109, 111 (6.286)
Table 1 Numbers of residues recognized as belonging to active site
according to: the close vicinity of residues versus the ligand center of
gravity defined as distance below 10 Å and below 15 Å (numbers in
parenthesis), according to SuMo in form of ligand defined and ligand
not defined (the score values are given in parentheses) and according
to fuzzy-oil-drop
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[47–49]. Geometry-based methods have shown that the
location of active-site residues can be identified by
searching for cavities in the protein structure [50] or by
docking small molecules onto the structure [51]. Cavity
localization in silico has been presented on the basis of the
characteristics of the normal (perpendicular to the local
surface) created for each portion of surface [52]. A complex
analysis of protein interfaces and their characteristics versus
highly divergent areas is presented in [53]. Several
experimental studies have shown that mutations of residues
involved in forming interfaces with other proteins or
ligands can be replaced to produce more stable but inactive
proteins [54–57]. On this basis, several effective algorithms
have been developed [58, 59]. Finally, structural analysis
coupled with measures of surface hydrophobicity has been
used to identify sites on the surfaces of proteins involved in
protein–protein interactions [60, 61].
The Critical Assessment of PRedicted Interaction
(CAPRI) is oriented on blind prediction of protein
complexes with ligands and protein–protein complex
creation [62–66]. The results of competitions are presented
on a web site (http://www.capri.ebi.ac.uk) and additionally
published in Proteins Struc Func Gen (2003) 52 (the whole
volume is devoted to this problem). The articles presented
there show methods aimed at complex creation based
mostly on detailed geometric surface analysis focused on
the search for irregularities and cavities [67].
The method presented in this paper is especially
dedicated for proteins of active site localized deep in the
protein body. The amino acids of high negative values of
ΔHi are understood as an area of higher than expected
hydrophobicity. Those localized on the surface may suggest
the area of potential protein–protein interaction area. The
amino acids of high positive values of ΔHi are interpreted
as the area of lower than expected hydrophobicity. These
fragments may be localized in close vicinity of the cavity
ready to bind the ligand. The limitation of the described
method is under consideration currently and will be
published soon.
The results obtained by fuzzy-oil-drop model confronted
with SuMo results and the data based on the crystal
structure seem to be satisfactory. The best agreement is
achieved for ribonuclease (1RGE) probably due to the high
quality of crystallographic model and the diffraction data
(measured by R-value) (R-value 0.109, resolution 1.15 Ǻ).
The high score given by SuMo appeared for the highest
accordance of results with those based on fuzzy-oil-drop.
The lowest accordance has been obtained for lysozyme
(1LMQ). Probably due to poor determination of the protein
structure (R-value 0.165, resolution 1.60 Ǻ) from the
diffraction experiment. In summary, one may conclude that
the accordance between crystal analysis, SuMo- and fuzzy-
oil-drop-based results seems to be satisfactory.
The commonly accepted model describing the folding
process treats the optimal backbone conformation (peptide
bond planes) as the initial step in the approach to protein
native structure [68–71]. The second step, expressed by
hydrophobic collapse, seems to organize the protein
molecule, leading to its native structural form. The fuzzy-
oil-drop model applied to folding BPTI [72], ribonuclease
[73], lysozyme [74], and hemoglobin [75] produced
structures close to their native ones. The presence of
hydrophobic density irregularities seems to be aim-oriented.
A folding process exactly following the path determined by
the ideal hydrophobicity distribution could produce a
soluble molecule unable to create any complex needed to
display the biological activity characteristic for a particular
protein molecule. The presence of a ligand or a molecule
mimicking the prospective ligand seems to be necessary
during folding simulation, ensuring the creation of the
cavity of high specificity. The folding of α and β chains of
hemoglobin in the absence of heme in a fuzzy-oil-drop form
external force field led toward structure with a regular
hydrophobicity distribution [75]. The CASP5 competition
[76] gave precedence to protein structure prediction
conditioned by the presence of a ligand (hem), giving
additional recognition of the necessity for a ligand to
participate in the folding process.
The method presented in this paper addresses the
localization of the possible binding site. If the binding cavity
is localized correctly, the compatible ligand (its shape and
chemical characteristics) can be constructed using classical
de novo design methods for ligand construction [77–80].
The conclusion given above may influence the construc-
tion of models for protein folding process simulation. The
folding process recognized experimentally as multi-step
process may be shown in a simplified as follows:
U ! I1 ! . . . ! Ii ! . . . ! N :
The unfolded structural form (U) is transformed into the
first intermediate (I1). The number of intermediates (Ii) is
unknown and presumably dependents on a particular
protein or group of proteins. The final native structure (N)
appears probably as the last one in a sequence of
conformational modifications.
The model developed (part of which is presented in this
paper) assumes the two-step process with following
intermediates:
U ! ES ! LS ! N
The unfolded state (U) representing the starting event
adopts the early-stage conformation (ES), which is deter-
mined by backbone conformation presented formerly [81–
83] and applied to folding simulation of few proteins [68,
83–85]. The sequence-to-structure (ES) relation generalized
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in form of contingency table allowed application to any
protein under consideration [69, 86, 87].
The ES form changed to late-stage (LS), which is mostly
driven by hydrophobic interaction between side chains is
supposed to approach the native structure (N) of the protein.
The LS conformation of protein can be created in silico
according to the fuzzy-oil-drop model [72, 74, 88]. The
results presented in this paper (as well as other results [73,
75, 89, 90]) suggest that the active presence of ligand
during the protein folding process influencing mutually
conformation of both molecules may ensure creation of
highly specific ligand binding cavity [73, 75].
In consequence, the simulation of protein folding
process can be presented as follows:
Initial results [72–75, 88–90] encourage large-scale
computational experiments, suitable for the grid environ-
ment. Further simulations are planned as a part of the
“Never Born Proteins” project in the application layer of the
EUChinaGRID initiative.
The procedure for folding simulation according to the
presented model requires the knowledge of ligand molecule
properties (e.g., their electronic structures, partial charges,
van der Waals parameters). Presently, such detailed chemical
characteristics of ligand (substrate) molecules is not available
in a consistent form. Therefore, one of our goals is to create
the library delivering the parameters describing the molecules
found as protein ligand in the Protein Data Bank (PDB) [91].
The ligand properties are calculated using quantum chemical
methods. The optimal geometry of ground state and the
atomic partial charges of isolated ligand molecules as well as
their energy are calculated using the Amsterdam Density
Functional (ADF) [92] in the TZV extended basis set (Slater
type functions) with BP86 exchange correlation functional.
The atomic charges are calculated according to Mulliken
population analysis [93] and Hirshfeld analysis [94]. We
plan, also, enclose similar properties computed by Gaussian
package [95] for comparison (e.g., partial charges implying
from the fitting of electrostatic potential [96]). The service is
progressively available on the http://www.bioinformatics.
cm-uj.krakow.pl/ligand website.
Availability
The active site can be easily predicted for any protein
structure according to the presented model, with the free
prediction server available at http://www.bioinformatics.
cm-uj.krakow.pl/activesite.
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